New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)

類似資料

• New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
  著者:: van Gorp, Rick H., 等
  出版事項: (2015)
• Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
  著者:: van Gorp, Rick H., 等
  出版事項: (2021)
• Optimizing quality care for the oral vitamin K antagonists (VKAs)
  著者:: Pengo, Vittorio, 等
  出版事項: (2018)
• Direct Oral Anticoagulant removal by a DOAC filter: Impact on lupus anticoagulant testing – Evaluation on spiked and patient samples
  著者:: Eleni A. Linskens, 等
  出版事項: (2022-02-01)
• Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
  著者:: Heng Cai, 等
  出版事項: (2020-01-01)